bioMerieux, a world leader in the field of in vitro diagnostics, today announces that its BIOFIRE(r) SPOTFIRE(r) Respiratory/Sore Throat (R/ST) Panel Mini has received U.S. Food and Drug Administration (FDA) Special 510(k) clearance and CLIA-waiver (Clinical Laboratory Improvement Amendments).
